Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share. The Class A ordinary shares have been approved for listing on the Nasdaq ...

Anbio Biotechnology, a global medical technology company focused on in vitro diagnostics, has successfully closed its initial public offering of 1,600,000 Class A ordinary shares at a price of $5. ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Frankfurt am Main, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology ...

In this dynamic environment, identifying small-cap stocks like Anbio Biotechnology that possess strong growth potential and innovative capabilities can offer intriguing opportunities for investors ...

09:59 EDT Anbio Biotechnology (NNNN) trading halted, volatility trading pause Effectively assess a stock's risks and opportunities with a clear breakdown of its positive and negative factors.

Write to [email protected] Anbio Biotechnology Registered NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The United States market has experienced a flat performance over the last week but has seen an 8.1% increase over the past year with earnings projected to grow by 14% annually. In this environment, ...

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology ...